ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Intramural Review System Described

September 10, 1982

Fellowships In Japan Available Through NIH

October 13, 1995

Daily Aspirin May Reduce Risk By 20 Percent, Study Says

February 28, 2014

DCPC Board To hear To Hear Concept for Contract to Develop Program For Heavy Smokers

January 11, 1985

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005